FindTrial
Sign In

Prospective Multicentre Randomization Study of Combination Chemotherapy With or Without Radiotherapy in Chinese Children With Newly Diagnosed Favorable Histology Stage ?A Wilms Tumor

Prospective Multicentre Randomization Study of Combination Chemotherapy With or Without Radiotherapy in Chinese Children With Newly Diagnosed Favorable Histology Stage ?A Wilms Tumor

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-PRRC-12002525
Enrollment
Unknown
Registered
2012-09-17
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilms Tumor

Interventions

Experimental group:Without Radiotherapy
Control group:With Radiotherapy

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Favorable-histology Wilms tumor patients with stage IIIA confirmed by pathology at initial diagnosis; 2. Patients aged <=18 years old; 3. Informed consent is required and signed by guardian.

Exclusion criteria

Exclusion criteria: 1. patients with relapsed Wilms tumor; 2. patients Older than 18 years old; 3. Patients with other tumors and previously received chemotherapy and abdominal irradiation; 4. Contralateral nephropathy, for example nephrotic syndrome; 5. Patients with heart, cerebral and renal failure.

Design outcomes

Primary

MeasureTime frame
Local relapse rate;Event free survival rate;Overall survival rat;—

Secondary

MeasureTime frame
Acute toxicity;Late toxicit;—

Countries

China

Contacts

Public ContactXiao-Fei Sun
sunxf@sysucc.org.cn+86 13600099837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026